Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05146700
Other study ID # 6011
Secondary ID 2021-000556-19NN
Status Active, not recruiting
Phase Phase 4
First received
Last updated
Start date December 10, 2021
Est. completion date June 1, 2024

Study information

Verified date October 2023
Source Rigshospitalet, Denmark
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Victims of trauma are often healthy individuals prior to the incident, but acquire numerous complications including sepsis and pulmonary complications and diminished quality of life after trauma. According to Advanced Trauma Life Support guidelines, all severely injured trauma patients should receive supplemental oxygen. The objective of TRAUMOX2 is to compare the effect of a restrictive versus liberal oxygen strategy the first eight hours following trauma on the incidence of 30-day mortality and/or major respiratory complications (pneumonia and acute respiratory distress syndrome) within 30 days (combined primary endpoint).


Description:

In trauma resuscitation, supplemental oxygen is often administered both to treat and prevent hypoxemia as recommended both by the Advanced Trauma Life Support (ATLS) manual and the Pre-hospital Trauma Life Support (PHTLS) manual. Oxygen is administered in many other situations too, sometimes in a non-consistent manner and very often without even being prescribed. In a recent systematic review, our group found the evidence both for and against the use of supplemental oxygen in the trauma population to be extremely sparse. However, a recent systematic review and meta-analysis comparing liberal versus restrictive oxygen strategy for a broad mix of acutely ill medical and surgical patients found an association between liberal oxygen administration and increased mortality. Of note, only one small study on trauma patients (patients with traumatic brain injury), which did not report mortality data, was included. Conversely, this study showed that degree of disability was significantly reduced at six months in the group receiving liberal compared to restrictive oxygen. In mechanically ventilated patients hyperoxemia is commonly observed (16-50%), and hyperoxemia is a common finding in trauma patients in general. In addition to mortality, hyperoxemia has been associated with major pulmonary complications in the Intensive Care Unit (ICU) as well as in surgical patients. For example, a recent retrospective study found hyperoxemia to be an independent risk factor for ventilator associated pneumonia (VAP). Nevertheless, a highly debated recommendation from the World Health Organisation strongly recommends that adult patients undergoing general anesthesia for surgical procedures receive a fraction of inspired oxygen (FiO2) of 80% intraoperatively as well as in the immediate postoperative period for two to six hours to reduce the risk of surgical site infection. Furthermore, a study on 152,000 mechanically ventilated patients found no association between hyperoxia and mortality during the first 24 hours in the ICU, and another study on 14,000 mixed ICU patients found that a partial arterial oxygen pressure (PaO2) of approximately 18 kPa resulted in the lowest mortality. Finally, a recent study randomized 2928 ICU patients to either low or high oxygenation (defined as 8 vs 12 kPa) for a maximum of 90 days and found no difference in mortality. Therefore, whether the trauma population could benefit from a more restrictive supplemental oxygen approach than recommended by current international guidelines presents a large and important knowledge gap. In a recent pilot randomized clinical trial (TRAUMOX1, ClinicalTrials.gov Registration number: NCT03491644), we compared a restrictive and a liberal oxygen strategy for 24 hours after trauma (N = 41) and found maintenance of normoxemia following trauma using a restrictive oxygen strategy to be feasible. TRAUMOX1 served as the basis for this larger trial. We experienced 24 hours to be slightly excessive to represent only the acute phase post trauma for which reason we have shortened the time-period to eight hours in TRAUMOX2. Furthermore, we found that several physicians had important concerns with the high dosage of oxygen in the liberal arm for which reason the concentration will be reduced. Finally, we did not randomize trauma patients in the pre-hospital phase, but instead on arrival at the trauma bay (median [interquartile range (IQR)] time to randomization: 7 [4-10] minutes, median [IQR] time from trauma to trauma bay arrival: 51 [29.0-67.5] minutes). To limit this inconsistent exposure to oxygen in the pre-hospital phase prior to inclusion we will initiate the intervention in the pre-hospital phase where possible in TRAUMOX2. The objective of TRAUMOX2 is to compare the effect of a restrictive versus liberal oxygen strategy the first eight hours following trauma on the incidence of 30-day mortality and/or major respiratory complications (pneumonia and acute respiratory distress syndrome) within 30 days (combined primary endpoint). We hypothesize that a restrictive compared to a liberal oxygen strategy for the initial eight hours after trauma will result in a lower rate of 30-day mortality and/or major respiratory complications (pneumonia and acute respiratory distress syndrome) within 30 days (combined primary endpoint).


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 1420
Est. completion date June 1, 2024
Est. primary completion date October 12, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients aged =18 years, including fertile women - Blunt or penetrating trauma mechanism - Direct transfer from the scene of accident to one of the participating trauma centers - Trauma team activation - The enrolling physician must initially expect a hospital length of stay for 24 hours or longer Exclusion Criteria: - Patients in cardiac arrest before or on admission - Patients with a suspicion of carbon monoxide intoxication - Patients with no/minor injuries after secondary survey will be excluded if they are expected to be discharged <24 hours

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Restrictive oxygen
Lowest oxygen delivery possible (=21%) ensuring an SpO2 target = 94%
Liberal oxygen
15 L O2/min flow for non-intubated trial participants or FiO2 = 1.0 for intubated trial participants in the initial phase; later in the operating room, intensive care unit, post-anesthesia care unit and ward, the flow/FiO2 can be reduced to =12 L O2/min or FiO2 =0.6 if the arterial oxygen saturation is =98%

Locations

Country Name City State
Denmark Aarhus University Hospital Aarhus
Denmark Rigshospitalet, Copenhagen University Hospital Copenhagen
Denmark Odense University Hospital Odense
Netherlands Erasmus MC, University Medical Center Rotterdam Rotterdam
Switzerland Inselspital University Hospital Bern Bern

Sponsors (2)

Lead Sponsor Collaborator
Rigshospitalet, Denmark The Novo Nordic Foundation

Countries where clinical trial is conducted

Denmark,  Netherlands,  Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary The incidence of 30-day mortality and/or major respiratory complications (pneumonia and acute respiratory distress syndrome) within 30 days (combined primary endpoint) The assessment of the major respiratory complications will be performed by at least two allocation blinded primary outcome assessors (specialists in anesthesiology, intensive care, emergency medicine or similar); blinding will be ensured by concealing all information indicative of the allocation prior to assessment Day 30 after enrollment
Secondary 30-day mortality Assessed in the patient's medical record/register Day 30 after enrollment
Secondary 12-month mortality Assessed in the patient's medical record/register 12 months after enrollment
Secondary Major respiratory complications (pneumonia and acute respiratory distress syndrome) within 30 days Data from the combined primary endpoint assessment Day 30 after enrollment
Secondary Hospital length of stay Number of days From date of admission to discharge from the hospital, up to 12 months after enrollment
Secondary ICU length of stay Number of days From date of admission to discharge from the ICU, up to 12 months after enrollment
Secondary Time on mechanical ventilation Number of hours; only mechanical ventilation in the ICU should be considered From initiation of mechanical ventilation to being ventilator-free within 30 days after enrollment
Secondary Days alive outside the ICU Number of days ICU-free days within 30 days after enrollment
Secondary Days alive without mechanical ventilation Number of days; only mechanical ventilation in the ICU should be considered Ventilator-free days within 30 days after enrollment
Secondary Re-intubations Number of re-intubations; only re-intubations in the ICU should be considered Within 30 days after enrollment
Secondary Pneumonia post-discharge Number of trial participants; evaluated through medicines prescribed after hospital discharge in countries where this information is available From discharge to a maximum of 30 days after enrollment
Secondary Episode(s) of hypoxemia during intervention (saturation <90%) Defined as number of times the valid oxygen saturation is below 90%; if it is below 90%, above 90% and below 90% again, then it should be registered as 2 episodes During the 8 hours of the oxygen intervention arms
Secondary Surgical site infections Defined as per the Centers for Disease Control and Prevention (CDC) criteria for a surgical site infection event Within 30 days after enrollment
Secondary 5-level EQ-5D version (EQ-5D-5L) score Conducted through a telephone interview where the patient is asked to indicate his/her health state
The EQ-5D-5L essentially consists of 2 pages: the EQ-5D descriptive system and the EQ visual analogue scale (EQ VAS)
The EQ-5D descriptive system consists of a scale (minimum score = 5 and maximum score = 25) where the lowest score (5) indicates no problems whereas the highest score (25) indicates extreme problems
The EQ VAS (visual analogue scale) records the patient's self-rated health on a vertical visual analogue scale, where the endpoints are labelled "The worst health you can imagine" (minimum score = 0) and "The best health you can imagine' (maximum score = 100)
6 and 12 months post-trauma
Secondary The Glasgow Outcome Scale Extended (GOSE) score Conducted through a telephone interview where the patient/patient's next-of-kin/caretaker is interviewed through a structured questionnaire to assess the functional recovery after trauma
The GOSE consists of a scale (minimum value = 1 and maximum value = 8); each patient given a score based on the interview:
1 = Death, 2 = Vegetative state, 3 = Lower severe disability, 4 = Upper severe disability, 5 = Lower moderate disability, 6 = Upper moderate disability, 7 = Lower good recovery, 8 = Upper good recovery
6 and 12 months post-trauma
Secondary Levels of oxidative stress biomarkers, primarily malondialdehyde (MDA) at hour 24 The unit of the oxidative stress biomarker depends on the chosen analysis of the specific biomarker Hour 0, hour 8, hour 24 and hour 48 after enrollment
See also
  Status Clinical Trial Phase
Recruiting NCT04848376 - Post-Market Clinical Follow-up Study of A-SPINE's Products
Terminated NCT03781817 - Intranasal Versus Intravenous Ketamine for Procedural Sedation in Children With Non-operative Fractures Phase 4
Completed NCT04342416 - Using a Brief Visuospatial Interference Intervention to Reduce Intrusive Memories Among Trauma Exposed Women N/A
Recruiting NCT04856449 - DBT Skills Plus EMDR for BPD and Trauma N/A
Completed NCT04356963 - Adjunct VR Pain Management in Acute Brain Injury N/A
Completed NCT05669313 - The Effects of Hypothermia and Acidosis on Coagulation During Treatment With Rivaroxaban Measured With ROTEM
Active, not recruiting NCT03622632 - Pilot Study to Measure Uric Acid in Traumatized Patients: Determinants and Prognostic Association
Recruiting NCT04725721 - Testing FIRST in Youth Outpatient Psychotherapy N/A
Active, not recruiting NCT05530642 - An Augmented Training Program for Preventing Post-Traumatic Stress Injuries Among Diverse Public Safety Personnel N/A
Not yet recruiting NCT05649891 - Checklists Resuscitation Emergency Department N/A
Not yet recruiting NCT03696563 - FreeO2 PreHospital - Automated Oxygen Titration vs Manual Titration According to the BLS-PCS N/A
Withdrawn NCT03249129 - Identification of Autoantibodies and Autoantigens in the Cerebrospinal Fluid of Patients With Spinal Cord Trauma
Completed NCT02240732 - Surgical Tourniquets and Cerebral Emboli N/A
Completed NCT02227979 - Effects of PURPLE Cry Intervention N/A
Withdrawn NCT01169025 - Fentanyl vs. Low-Dose Ketamine for the Relief of Moderate to Severe Pain in Aeromedical Patients N/A
Recruiting NCT01812941 - Evaluation of Mitochondrial Dysfunction in Severe Burn and Trauma Patients N/A
Completed NCT03112304 - Child STEPS for Youth Mental Health in Maine Sustainability N/A
Completed NCT01475344 - Fibrinogen Concentrate (FGTW) in Trauma Patients, Presumed to Bleed (FI in TIC) Phase 1/Phase 2
Completed NCT01201863 - Neuroendocrine Dysfunction in Traumatic Brain Injury: Effects of Testosterone Therapy Phase 4
Completed NCT01210417 - Trauma Heart to Arm Time N/A